David S Hong | MD Anderson Cancer Center

Dr. David Hong, MD

Claim this profile

M D Anderson Cancer Center

Expert in Solid Tumors
Studies Uterine Tumors
32 reported clinical trials
61 drugs studied

Area of expertise

1Solid Tumors
Global Leader
David Hong, MD has run 11 trials for Solid Tumors. Some of their research focus areas include:
Stage IV
Stage III
KRAS positive
2Uterine Tumors
David Hong, MD has run 10 trials for Uterine Tumors. Some of their research focus areas include:
Stage IV
Stage III
NTRK positive

Affiliated Hospitals

Image of trial facility.
M D Anderson Cancer Center
Image of trial facility.
The University Of Texas M.D. Anderson Cancer Center

Clinical Trials David Hong, MD is currently running

Image of trial facility.

Larotrectinib

for Advanced or Metastatic Cancer

This phase II trial studies the effect of larotrectinib in treating patients with NTRK gene amplification positive solid tumors that have spread to nearby tissues or lymph nodes (locally advanced) or other places in the body (metastatic). Larotrectinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 214 criteria
Image of trial facility.

QTX3046 + Cetuximab

for Solid Tumors

Phase 1 study to determine the safety and tolerability of QTX3046 as a single agent or in combination with cetuximab.
Recruiting1 award Phase 12 criteria

More about David Hong, MD

Clinical Trial Related4 years of experience running clinical trials · Led 32 trials as a Principal Investigator · 12 Active Clinical Trials
Treatments David Hong, MD has experience with
  • Pembrolizumab
  • Cetuximab
  • Radiation Therapy
  • Ipilimumab
  • ADP-A2M4CD8
  • Irinotecan Hydrochloride
Breakdown of trials David Hong, MD has run
Solid Tumors
Uterine Tumors
Thyroid Cancer
Colorectal Cancer
Stomach Cancer

Other Doctors you might be interested in

Rebecca Harrison, MDBC Cancer - The Vancouver Center
Qian Lu, MDM D Anderson Cancer Center
Lois M RamondettaM D Anderson Cancer Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Hong, MD specialize in?
David Hong, MD focuses on Solid Tumors and Uterine Tumors. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is David Hong, MD currently recruiting for clinical trials?
Yes, David Hong, MD is currently recruiting for 12 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that David Hong, MD has studied deeply?
Yes, David Hong, MD has studied treatments such as Pembrolizumab, Cetuximab, Radiation Therapy.
What is the best way to schedule an appointment with David Hong, MD?
Apply for one of the trials that David Hong, MD is conducting.
What is the office address of David Hong, MD?
The office of David Hong, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top